NFL Biosciences (XPAR:ALNFL) Marketable Securities : €0.19 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is NFL Biosciences Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. NFL Biosciences's Marketable Securities for the quarter that ended in Dec. 2023 was €0.19 Mil.

NFL Biosciences's annual Marketable Securities declined from Dec. 2021 (€0.17 Mil) to Dec. 2022 (€0.16 Mil) but then increased from Dec. 2022 (€0.16 Mil) to Dec. 2023 (€0.19 Mil).

NFL Biosciences Marketable Securities Historical Data

The historical data trend for NFL Biosciences's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NFL Biosciences Marketable Securities Chart

NFL Biosciences Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

0.17

0.16

0.19

NFL Biosciences Semi-Annual Data
	Dec19	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Marketable Securities	Get a 7-Day Free Trial			0.17	0.09	0.16	0.20	0.19

NFL Biosciences Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

NFL Biosciences (XPAR:ALNFL) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

NFL Biosciences Marketable Securities Related Terms

Thank you for viewing the detailed overview of NFL Biosciences's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

NFL Biosciences (XPAR:ALNFL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NFL Biosciences SA (XPAR:ALNFL) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

82F:Germany

Address

199 rue Helene Boucher, Castelnau-le-Lez, FRA, 34170

Website

https://www.nflbiosciences.com/

NFL Biosciences SA specializes in the research and development of medicines to combat tobacco addiction that use botanical and pharmaceutical agents. NFL-101 is company's core product, targeting smoking addiction. It is a clinically developed, botanical drug that contains an insignificant amount of nicotine and is composed of well characterized, natural tobacco leaf proteins.

NFL Biosciences (XPAR:ALNFL) Headlines

No Headlines